Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients

Journal of Neurochemistry

Volumn 130, Issue 4, 2014, Pages 591-597

  Caruso, Donatella ^a   Melis, Marta ^b   Fenu, Giuseppe ^b   Giatti, Silvia ^a   Romano, Simone ^a   Grimoldi, Maria ^c,d   Crippa, Donatella ^e   Marrosu, Maria Giovanna ^b   Cavaletti, Guido ^c,d   Melcangi, Roberto Cosimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d SAN GERARDO HOSPITAL   (Italy)

^e Bayer SpA Italy   (Italy)

Author keywords

liquid chromatography tandem mass spectrometry; neurosteroids; pregnenolone; progesterone metabolites; relapsing remitting multiple sclerosis; testosterone metabolites

Indexed keywords

20ALPHA DIHYDROPROGESTERONE; ANDROSTANEDIOL; ESTRADIOL; PREGNENOLONE; PROGESTERONE; SEPRANOLONE; TETRAHYDROPROGESTERONE;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; ISOELECTRIC FOCUSING; LIQUID CHROMATOGRAPHY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; STEROID BLOOD LEVEL; TANDEM MASS SPECTROMETRY;

LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; NEUROSTEROIDS; PREGNENOLONE; PROGESTERONE METABOLITES; RELAPSING-REMITTING MULTIPLE SCLEROSIS; TESTOSTERONE METABOLITES;

ADULT; BLOOD-BRAIN BARRIER; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; ISOELECTRIC FOCUSING; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; SPINAL PUNCTURE; STEROIDS; TANDEM MASS SPECTROMETRY;

EID: 84905749048     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12745     Document Type: Article

References (36)

1. Caruso D., D'Intino G., Giatti S., Maschi O., Pesaresi M., Calabrese D., Garcia-Segura L. M., Calza L., and, Melcangi R. C., (2010) Sex-dimorphic changes in neuroactive steroid levels after chronic experimental autoimmune encephalomyelitis. J. Neurochem. 114, 921-932.
2. Caruso D., Barron A. M., Brown M. A., Abbiati F., Carrero P., Pike C. J., Garcia-Segura L. M., and, Melcangi R. C., (2013a) Age-related changes in neuroactive steroid levels in 3xTg-AD mice. Neurobiol. Aging 34, 1080-1089.
3. Caruso D., Pesaresi M., Abbiati F., Calabrese D., Giatti S., Garcia-Segura L. M., and, Melcangi R. C., (2013b) Comparison of plasma and cerebrospinal fluid levels of neuroactive steroids with their brain, spinal cord and peripheral nerve levels in male and female rats. Psychoneuroendocrinology 38, 2278-2290.
4. Cerciat M., Unkila M., Garcia-Segura L. M., and, Arevalo M. A., (2010) Selective estrogen receptor modulators decrease the production of interleukin-6 and interferon-gamma-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro. Glia 58, 93-102.
5. Confavreux C., Vukusic S., and, Adeleine P., (2003) Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126, 770-782.
6. Dalal M., Kim S., and, Voskuhl R. R., (1997) Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J. Immunol. 159, 3-6.
7. El-Etr M., Vukusic S., Gignoux L., Durand-Dubief F., Achiti I., Baulieu E. E., and, Confavreux C., (2005) Steroid hormones in multiple sclerosis. J. Neurol. Sci. 233, 49-54.
8. Foster S. C., Daniels C., Bourdette D. N., and, Bebo B. F., Jr, (2003) Dysregulation of the hypothalamic-pituitary-gonadal axis in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Neuroimmunol. 140, 78-87.
9. Freedman M. S., Thompson E. J., Deisenhammer F., et al,. (2005) Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch. Neurol. 62, 865-870.
10. Garcia-Segura L. M., and, Melcangi R. C., (2006) Steroids and glial cell function. Glia 54, 485-498.
11. Giatti S., D'Intino G., Maschi O., Pesaresi M., Garcia-Segura L. M., Calza L., Caruso D., and, Melcangi R. C., (2010) Acute experimental autoimmune encephalomyelitis induces sex dimorphic changes in neuroactive steroid levels. Neurochem. Int. 56, 118-127.
12. Ibanez C., Shields S. A., El-Etr M., Baulieu E. E., Schumacher M., and, Franklin R. J., (2004) Systemic progesterone administration results in a partial reversal of the age-associated decline in CNS remyelination following toxin-induced demyelination in male rats. Neuropathol. Appl. Neurobiol. 30, 80-89.
13. Khalaj A. J., Yoon J., Nakai J., et al,. (2013) Estrogen receptor (ER) beta expression in oligodendrocytes is required for attenuation of clinical disease by an ERbeta ligand. Proc. Natl Acad. Sci. USA 110, 19125-19130.
14. Kipp M., and, Beyer C., (2009) Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis. Front. Neuroendocrinol. 30, 188-200.
15. Labombarda F., Pianos A., Liere P., Eychenne B., Gonzalez S., Cambourg A., De Nicola A. F., Schumacher M., and, Guennoun R., (2006) Injury elicited increase in spinal cord neurosteroid content analyzed by gas chromatography mass spectrometry. Endocrinology 147, 1847-1859.
16. Labombarda F., Gonzalez S. L., Lima A., Roig P., Guennoun R., Schumacher M., and, de Nicola A. F., (2009) Effects of progesterone on oligodendrocyte progenitors, oligodendrocyte transcription factors, and myelin proteins following spinal cord injury. Glia 57, 884-897.
17. Leitner H., (2010) Influence of neurosteroids on the pathogenesis of multiple sclerosis. Med. Hypotheses 75, 229-234.
18. Luchetti S., Huitinga I., and, Swaab D. F., (2011) Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis. Neuroscience 191, 6-21.
19. Meffre D., Pianos A., Liere P., Eychenne B., Cambourg A., Schumacher M., Stein D. G., and, Guennoun R., (2007) Steroid profiling in brain and plasma of male and pseudopregnant female rats after traumatic brain injury: analysis by gas chromatography/mass spectrometry. Endocrinology 148, 2505-2517.
20. Melcangi R. C., and, Garcia-Segura L. M., (2010) Sex-specific therapeutic strategies based on neuroactive steroids: In search for innovative tools for neuroprotection. Horm. Behav. 57, 2-11.
21. Melcangi R. C., Garcia-Segura L. M., and, Mensah-Nyagan A. G., (2008) Neuroactive steroids: state of the art and new perspectives. Cell. Mol. Life Sci. 65, 777-797.
22. Melcangi R. C., Panzica G., and, Garcia-Segura L. M., (2011) Neuroactive steroids: focus on human brain. Neuroscience 191, 1-5.
23. Melcangi R. C., Caruso D., Abbiati F., Giatti S., Calabrese D., Piazza F., and, Cavaletti G., (2013) Neuroactive steroid levels are modified in cerebrospinal fluid and plasma of post-finasteride patients showing persistent sexual side effects and anxious/depressive symptomatology. J. Sex. Med. 10, 2598-2603.
24. Melcangi R. C., Giatti S., Calabrese D., Pesaresi M., Cermenati G., Mitro N., Viviani B., Garcia-Segura L. M., and, Caruso D., (2014) Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions. Prog. Neurobiol. 113, 56-69.
25. Nicot A., (2009) Gender and sex hormones in multiple sclerosis pathology and therapy. Front. Biosci. 14, 4477-4515.
26. Noorbakhsh F., Ellestad K. K., Maingat F., Warren K. G., Han M. H., Steinman L., Baker G. B., and, Power C., (2011) Impaired neurosteroid synthesis in multiple sclerosis. Brain 134, 2703-2721.
27. Panzica G. C., Balthazart J., Frye C. A., Garcia-Segura L. M., Herbison A. E., Mensah-Nyagan A. G., McCarthy M. M., and, Melcangi R. C., (2012) Milestones on Steroids and the Nervous System: 10 years of basic and translational research. J. Neuroendocrinol. 24, 1-15.
28. Papenfuss T. L., Powell N. D., McClain M. A., Bedarf A., Singh A., Gienapp I. E., Shawler T., and, Whitacre C. C., (2011) Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity. J. Immunol. 186, 3346-3355.
29. Pesaresi M., Maschi O., Giatti S., Garcia-Segura L. M., Caruso D., and, Melcangi R. C., (2010) Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats. Horm. Behav. 57, 46-55.
30. Polman C. H., Reingold S. C., Banwell B., et al,. (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 69, 292-302.
31. Safarinejad M. R., (2008) Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in multiple sclerosis. J. Neuroendocrinol. 20, 1368-1375.
32. Spence R. D., and, Voskuhl R. R., (2012) Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. Front. Neuroendocrinol. 33, 105-115.
33. Voskuhl R. R., and, Palaszynski K., (2001) Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 7, 258-270.
34. Vukusic S., and, Confavreux C., (2006) Pregnancy and multiple sclerosis: the children of PRIMS. Clin. Neurol. Neurosurg. 108, 266-270.
35. Wei T., and, Lightman S. L., (1997) The neuroendocrine axis in patients with multiple sclerosis. Brain 120, 1067-1076.
36. Weill-Engerer S., David J. P., Sazdovitch V., et al,. (2002) Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients. J. Clin. Endocrinol. Metab. 87, 5138-5143.